You have 6 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dermatitis, Exfoliative

Showing 1 - 25 of 1,737
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pityriasis Rubra Pilaris Trial in Portland (guselkumab)

Active, not recruiting
  • Pityriasis Rubra Pilaris
  • guselkumab
  • Portland, Oregon
    Oregon Health and Science University
Apr 8, 2022

PITYRIASIS RUBRA PILARIS Trial in Scottsdale, Jacksonville (Cosentyx)

Completed
  • PITYRIASIS RUBRA PILARIS
  • Scottsdale, Arizona
  • +1 more
Feb 23, 2022

Moderate-to-severe Psoriasis in Adults: Update of French

Recruiting
  • Psoriasis
  • +10 more
  • Experts consensus
  • Paris, France
    Center of Evidence of Dermatology
Nov 21, 2021

Ichthyosis, Autosomal Recessive Congenital Ichthyosis, Lamellar Ichthyosis Trial in Chicago, New York (Secukinumab, Placebo)

Completed
Has Results
  • Ichthyosis
  • +5 more
  • Chicago, Illinois
  • +1 more
Aug 2, 2021

Pityriasis Rubra Pilaris Trial in Portland (Ixekizumab)

Completed
Has Results
  • Pityriasis Rubra Pilaris
  • Portland, Oregon
    Oregon Health and Science University
Jun 15, 2020

Psoriasis Vulgaris, Psoriatic Arthritis, Pustular; Psoriasis, Palmaris Et Plantaris Trial in Tokyo (Brodalumab 210mg SC)

Completed
  • Psoriasis Vulgaris
  • +3 more
  • Brodalumab 210mg SC
  • Tokyo, Japan
    The Jikei University Scoole of Medicine
Dec 5, 2019

Psoriasis Vulgaris, Psoriatic Arthritis, Pustular; Psoriasis, Palmaris Et Plantaris Trial in Chiyoda-ku (KHK4827 140mg SC,

Completed
  • Psoriasis Vulgaris
  • +3 more
  • KHK4827 140mg SC
  • KHK4827 210mg SC
  • Chiyoda-ku, Tokyo, Japan
    For additional information regarding investigative sites for thi
Nov 13, 2019

Dermatitis, Atopic Trial in Canada, Japan, United States (BI 655130, Placebo)

Completed
Has Results
  • Dermatitis, Atopic
  • BI 655130
  • Placebo
  • Scottsdale, Arizona
  • +22 more
Nov 15, 2022

NSCLC Trial (Amivantamab, Lazertinib, Doxycycline)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Nov 7, 2023

Suprachoroidal Tube Shunt in Primary Open and Pseudoexfoliation

Recruiting
  • Glaucoma, Open-Angle
  • +2 more
    • Tbilisi, Georgia
      Davinci Eye Center, LTD
    Nov 23, 2023

    Atopic Dermatitis Trial in United States (nemolizumab (CIM331), Placebo)

    Completed
    Has Results
    • Atopic Dermatitis
    • nemolizumab (CIM331)
    • Placebo
    • Anniston, Alabama
    • +17 more
    Jan 18, 2022

    Atopic Dermatitis Trial in Worldwide (Baricitinib, Placebo)

    Active, not recruiting
    Has Results
    • Atopic Dermatitis
    • Caba, Buenos Aires, Argentina
    • +184 more
    Jun 7, 2022

    Photodamaged Skin Trial (Vitamin C with AHA Exfoliative Serum, Placebo serum)

    Not yet recruiting
    • Photodamaged Skin
    • Vitamin C with AHA Exfoliative Serum
    • Placebo serum
    • (no location specified)
    Jun 19, 2023

    Oral HPV Infection in Patients Who Are Positive to the PAP-test

    Recruiting
    • HPV Infection
      • Catania, Italy
        AOU Policlinico G. Rodolico
      Jul 13, 2023

      Acanthosis Nigricans Trial in Karachi (Topical 15% Trichloroacetic acid)

      Completed
      • Acanthosis Nigricans
      • Topical 15% Trichloroacetic acid
      • Karachi, Sindh, Pakistan
        JPMC
      Aug 18, 2023

      Atopic Dermatitis Trial in Worldwide (Placebo, Upadacitinib, Topical corticosteroids (TCS))

      Active, not recruiting
      Has Results
      • Atopic Dermatitis
      • Placebo
      • +2 more
      • Birmingham, Alabama
      • +189 more
      Mar 8, 2022

      Diaper Dermatitis Healing Trial in Antalya (Use of restoderm in the healing of diaper dermatitis, Use of sudocrem in the healing

      Completed
      • Diaper Dermatitis Healing
      • Use of restoderm in the healing of diaper dermatitis
      • +2 more
      • Antalya, Kumluca/Antalya, Turkey
        Antalya Provincial Directorate of Health
      Nov 10, 2023

      Gastric Cancer Trial (Camrelizumab Nab-Paclitaxel S-1)

      Not yet recruiting
      • Gastric Cancer
      • Camrelizumab Nab-Paclitaxel S-1
      • (no location specified)
      Jun 20, 2022

      Moderate to Severe Atopic Dermatitis Trial in Worldwide (ISB 830 - Part 1 Group 1, ISB 830 - Part 1 Group 2, ISB 830 - Part 1

      Completed
      Has Results
      • Moderate to Severe Atopic Dermatitis
      • ISB 830 - Part 1 Group 1
      • +5 more
      • Birmingham, Alabama
      • +82 more
      Jul 26, 2022

      Atopic Dermatitis Trial in Worldwide (Placebo for Upadacitinib, Upadacitinib)

      Active, not recruiting
      Has Results
      • Atopic Dermatitis
      • Phoenix, Arizona
      • +179 more
      Feb 2, 2022

      Acne Vulgaris Trial (Dapsone gel)

      Not yet recruiting
      • Acne Vulgaris
      • Dapsone gel
      • (no location specified)
      Mar 24, 2022

      Dermatitis Herpetiformis Trial in Tampere (Assessment of prognosis of refractory dermatitis herpetiformis. No intervention)

      Enrolling by invitation
      • Dermatitis Herpetiformis
      • Assessment of prognosis of refractory dermatitis herpetiformis. No intervention
      • Tampere, Finland
        Tampere University Hospital
      Aug 18, 2023

      Atopic Dermatitis Trial in Sari (Baricitinib 4 MG, Azathioprine 1.5-2.5 mg/kg)

      Not yet recruiting
      • Atopic Dermatitis
      • Baricitinib 4 MG
      • Azathioprine 1.5-2.5 mg/kg
      • Sari, Mazandaran, Iran, Islamic Republic of
        Iran
      Aug 1, 2023

      Investigate Contact Sensitization Using Classic and Machine

      Recruiting
      • Allergic Contact Dermatitis
      • patch test for diagnosing allergic contact dermatitis
      • Athens, Attica, Greece
        Georgia Gogkla
      Aug 7, 2023

      Moderate to Severe Atopic Dermatitis Trial (SHR-1819 injection)

      Not yet recruiting
      • Moderate to Severe Atopic Dermatitis
      • SHR-1819 injection
      • (no location specified)
      Aug 22, 2023